Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pasithea Therapeutics (KTTA) Other Operating Expenses (2022)

Historic Other Operating Expenses for Pasithea Therapeutics (KTTA) over the last 1 years, with Q2 2022 value amounting to -$3.1 million.

  • Pasithea Therapeutics' Other Operating Expenses changed N/A to -$3.1 million in Q2 2022 from the same period last year, while for Mar 2023 it was -$3.1 million, marking a year-over-year change of. This contributed to the annual value of -$1.0 million for FY2022, which is N/A changed from last year.
  • Latest data reveals that Pasithea Therapeutics reported Other Operating Expenses of -$3.1 million as of Q2 2022.
  • In the past 5 years, Pasithea Therapeutics' Other Operating Expenses registered a high of -$3.1 million during Q2 2022, and its lowest value of -$3.1 million during Q2 2022.